Results 201 to 210 of about 2,266,569 (385)

Recurrence of Checkpoint Inhibitor Pneumonia More than Three Years after Discontinuation of an Immune Checkpoint Inhibitor [PDF]

, 2023
Tetsuo Fujita
openalex   +1 more source

Integrated Transcriptomics Reveals Evolutionary Trajectories and Cell Density‐Dependent Mechanisms in Aldosterone‐Producing Adenomas

Advanced Science, EarlyView.
Aldosterone‐producing adenomas (APAs) develop via two distinct paths: directly from adrenal zona glomerulosa (zG) cells, or stepwise from zG cells through aldosterone‐producing micronodules (APMs) before progressing to APAs. Advanced single‐cell and spatial analyses identified distinct cell states linked to oxidative stress and cell–cell interactions ...
Zhuolun Sun, Changying Jing, Martina Tetti, Siyuan Gong, Jia Wei, Yingxian Pang, Martin Reincke, Tracy Ann Williams   +7 more
wiley   +1 more source

Immune checkpoint TIM-3 in tumor immunotherapy. [PDF]

Acta Biochim Biophys Sin (Shanghai)
Ma S, Zhu M, Ma C, Li C.
europepmc   +1 more source

Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade

Hidetoshi Hayashi, Kenji Chamoto, Ryusuke Hatae, Takashi Kurosaki, Yosuke Togashi, Kazuya Fukuoka, Megumi Goto, Yasutaka Chiba, Shuta Tomida, Takayo Ota, Koji Haratani, Takayuki Takahama, Junko Tanizaki, Takeshi Yoshida, Tsutomu Iwasa, Kaoru Tanaka, Masayuki Takeda, T Hirano, Hironori Yoshida, Hiroaki Ozasa, Yuichi Sakamori, Kazuko Sakai, Keiko Higuchi, Hitoshi Uga, Chihiro Suminaka, Toyohiro Hirai, Kazuto Nishio, Kazuhiko Nakagawa, Tasuku Honjo   +28 more
openalex   +1 more source

The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma –CLEAP 004 study [PDF]

Chao-Xu Yang, Yangxun Pan, Feng Ye, Xiao‐Dong Zhu, Jun Xue, Xi Li, Zhen-Gang Yuan, Lan Zhang, Li Xu, Yongjun Chen, Nan-Ya Wang, Hui‐Chuan Sun, Xiufeng Liu, China Liver Cancer Study Group Young Investigators (CLEAP)   +13 more
openalex   +1 more source

Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity

Critical Care Medicine, 2019
Karthik, Suresh, Franco, D'Alessio
openaire   +3 more sources

FAPα+ Macrophages Orchestrate Immune Evasion in Multiple Myeloma by Dual Regulation of PD‐L1 and T Cell Senescence

Advanced Science, EarlyView.
Fibroblast activation protein alpha‐positive (FAPα+) macrophages, a distinct subset of multiple myeloma (MM)‐associated macrophages, drive immune evasion in MM through multi‐faceted mechanisms. FAPα physically interacts with vimentin (VIM) and triggers its phosphorylation at the S72 residue, which in turn induces PD‐L1 transcription. Additionally, FAPα
Huiyao Gu, Zhenfeng Dai, Xi Huang, Enfan Zhang, Xinyuan Dai, Haoguang Chen, Wen Cao, Jinna Zhang, Yifan Hou, Haimeng Yan, Yang Yang, Li Yang, Yi Li, Wenlong Lin, Zhen Cai, Jingsong He   +15 more
wiley   +1 more source

The role of immune checkpoint molecules in cancers. [PDF]

Front Immunol
Zhang M, Xu J, Zheng Z, Guo Z, Wang H, Zhou M, Tang H, Zhu L.   +7 more
europepmc   +1 more source

Data from A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy

, 2023
Fushun Fan, Pei Liu, Rudi Bao, Jian Chen, Minhua Zhou, Zhenxian Mo, Yaru Ma, Haiqi Liu, Yiping Zhou, Xiong Cai, Changgeng Qian, Xinjian Liu   +11 more
openalex   +1 more source

Immune checkpoint blockade: a common denominator approach to cancer therapy.

Cancer Cell, 2015
S. Topalian, C. Drake, D. Pardoll
semanticscholar   +1 more source